Is MAXCYTE, INC. (MXCT) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 21.6% / 30% | 185.1% / 30% | 5.6% / 30% | 26.26% / 5% | ✗ NOT HALAL |
| DJIM | 21.6% / 33% | 185.1% / 33% | 5.6% / 33% | 26.26% / 5% | ✗ NOT HALAL |
| MSCI | 7.5% / 33% | 64.5% / 33% | 2.0% / 33% | 26.26% / 5% | ✗ NOT HALAL |
| S&P | 21.6% / 33% | 185.1% / 33% | 5.6% / 33% | 26.26% / 5% | ✗ NOT HALAL |
| FTSE | 7.5% / 33% | 64.5% / 33% | 2.0% / 50% | 26.26% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 81.2% | |
| Operating Margin | -94.8% | |
| Net Margin | -135.1% | |
| Return on Equity (ROE) | -23.6% | |
| Return on Assets (ROA) | -12.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$28M |
| Free Cash Flow | -$29M |
| Total Debt | $18M |
| Debt-to-Equity | 10.5 |
| Current Ratio | 8.3 |
| Total Assets | $239M |
Price & Trading
| Last Close | $0.72 |
| 50-Day MA | $0.85 |
| 200-Day MA | $1.49 |
| Avg Volume | 1.1M |
| Beta | 1.4 |
|
52-Week Range
$0.64
| |
About MAXCYTE, INC. (MXCT)
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is MAXCYTE, INC. (MXCT) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), MAXCYTE, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is MAXCYTE, INC.'s debt ratio?
MAXCYTE, INC.'s debt ratio is 21.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 7.5%.
What are MAXCYTE, INC.'s key financial metrics?
MAXCYTE, INC. has a market capitalization of $73M, and revenue of $39M. The company maintains a gross margin of 81.2% and a net margin of -135.1%. Return on equity stands at -23.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.